EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6121 - ketamine
| Formula | C13H16ClNO |
| Net Charge | 0 |
| Average Mass | 237.730 |
| Monoisotopic Mass | 237.09204 |
| SMILES | CNC1(c2ccccc2Cl)CCCCC1=O |
| InChI | InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3 |
| InChIKey | YQEZLKZALYSWHR-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. neurotoxin A poison that interferes with the functions of the nervous system. NMDA receptor antagonist Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ketamine (CHEBI:6121) has functional parent norketamine (CHEBI:91519) |
| ketamine (CHEBI:6121) has role analgesic (CHEBI:35480) |
| ketamine (CHEBI:6121) has role environmental contaminant (CHEBI:78298) |
| ketamine (CHEBI:6121) has role intravenous anaesthetic (CHEBI:38877) |
| ketamine (CHEBI:6121) has role neurotoxin (CHEBI:50910) |
| ketamine (CHEBI:6121) has role NMDA receptor antagonist (CHEBI:60643) |
| ketamine (CHEBI:6121) has role xenobiotic (CHEBI:35703) |
| ketamine (CHEBI:6121) is a cyclohexanones (CHEBI:23482) |
| ketamine (CHEBI:6121) is a monochlorobenzenes (CHEBI:83403) |
| ketamine (CHEBI:6121) is a secondary amino compound (CHEBI:50995) |
| Incoming Relation(s) |
| ketamine hydrochloride (CHEBI:650657) has part ketamine (CHEBI:6121) |
| (R)-ketamine (CHEBI:580604) is a ketamine (CHEBI:6121) |
| esketamine (CHEBI:60799) is a ketamine (CHEBI:6121) |
| IUPAC Name |
|---|
| 2-(2-chlorophenyl)-2-(methylamino)cyclohexanone |
| INNs | Source |
|---|---|
| ketamina | WHO MedNet |
| ketamine | ChemIDplus |
| kétamine | WHO MedNet |
| ketaminum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone | ChEMBL |
| 2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone | ChemIDplus |
| 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone | ChemIDplus |
| dl-ketamine | ChemIDplus |
| (±)-ketamine | ChemIDplus |
| Ketamine | KEGG COMPOUND |
| Citations |
|---|